MedTrace Logo

Intensive Arterial Pressure Control in Acute Coronary Syndrome

NCT02135315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2022-08-24

No results posted yet for this study

Summary

The intensive arterial pressure control in acute coronary syndrome (ACS) during the first 24 hours can improve the prognosis in the short and long term.

the study compare two treatment strategies (standard and intensive treatment) to assess their efficacy and safety in the treatment of acute coronary syndrome.

Conditions

  • Acute Coronary Syndrome

Interventions

DRUG

Isosorbide Dinitrate

administration of continuous intravenous isosorbide dinitrate to obtain a SBP between 110 and 120 mmHg. After 2 hours from the start of treatment and if the blood pressure goal is not achieved, labetalol is used

Sponsors & Collaborators

  • Emergency NGO Onlus

    collaborator OTHER

  • University of Monastir

    lead OTHER

Principal Investigators

  • Semir Nouira, MD · University of Monastir

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02135315 on ClinicalTrials.gov